Peter Ellinghaus

4.1k total citations
74 papers, 3.1k citations indexed

About

Peter Ellinghaus is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Peter Ellinghaus has authored 74 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 25 papers in Surgery and 18 papers in Cancer Research. Recurrent topics in Peter Ellinghaus's work include Fibroblast Growth Factor Research (24 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Peter Ellinghaus is often cited by papers focused on Fibroblast Growth Factor Research (24 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Peter Ellinghaus collaborates with scholars based in Germany, United States and Spain. Peter Ellinghaus's co-authors include Udo Seedorf, Gerd Assmann, Ingo Flamme, Christian Wolfrum, Friedrich Spener, Khusru Asadullah, Isabella Gashaw, Anette Sommer, Felix Oehme and Frank Kannenberg and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Peter Ellinghaus

72 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Ellinghaus Germany	28	1.6k	544	519	465	444	74	3.1k
Anthony W. Ashton United States	35	1.8k 1.1×	575 1.1×	294 0.6×	379 0.8×	498 1.1×	87	3.7k
Alistair J. Ingram Canada	38	2.1k 1.3×	532 1.0×	350 0.7×	395 0.8×	395 0.9×	73	3.8k
Bruce A. Hug United States	23	1.6k 0.9×	291 0.5×	339 0.7×	502 1.1×	433 1.0×	47	3.6k
Carlos Fernández-Patrón Canada	30	966 0.6×	672 1.2×	271 0.5×	492 1.1×	394 0.9×	63	2.5k
Toshiji Saibara Japan	39	1.3k 0.8×	491 0.9×	868 1.7×	537 1.2×	569 1.3×	169	6.4k
Lakshmi Puttagunta Canada	23	1.5k 0.9×	812 1.5×	369 0.7×	325 0.7×	291 0.7×	62	3.3k
Phillip Kantharidis Australia	31	2.6k 1.6×	1.3k 2.4×	418 0.8×	189 0.4×	506 1.1×	64	4.3k
Paul Nicklin United Kingdom	23	1.8k 1.1×	516 0.9×	242 0.5×	259 0.6×	391 0.9×	40	3.3k
D P Via United States	25	1.4k 0.8×	612 1.1×	967 1.9×	335 0.7×	314 0.7×	46	3.2k
Christoph Daniel Germany	38	1.6k 0.9×	331 0.6×	493 0.9×	220 0.5×	525 1.2×	169	4.2k

Countries citing papers authored by Peter Ellinghaus

Since Specialization

Citations

This map shows the geographic impact of Peter Ellinghaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellinghaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellinghaus more than expected).

Fields of papers citing papers by Peter Ellinghaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ellinghaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellinghaus. The network helps show where Peter Ellinghaus may publish in the future.

Co-authorship network of co-authors of Peter Ellinghaus

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ellinghaus. A scholar is included among the top collaborators of Peter Ellinghaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ellinghaus. Peter Ellinghaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sweis, Randy F., Pablo Gajate, Rafael Morales‐Barrera, et al.. (2024). Rogaratinib Plus Atezolizumab in Cisplatin-Ineligible Patients With FGFR RNA-Overexpressing Urothelial Cancer. JAMA Oncology. 10(11). 1565–1565. 6 indexed citations

Ellinghaus, Peter, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing, & Matthias Ocker. (2022). Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?. Cells. 11(19). 3180–3180. 14 indexed citations

Mondritzki, Thomas, Philip Boehme, Julia Vogel, et al.. (2017). New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions. European Journal of Applied Physiology. 118(1). 195–203. 5 indexed citations

Flamme, Ingo, Peter Ellinghaus, Diana Urrego, & Thilo Krüger. (2017). FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase. PLoS ONE. 12(10). e0186979–e0186979. 62 indexed citations

Kim, H., Ji Min Lee, Hojin Choi, et al.. (2016). Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy. Oncogenesis. 5(7). e241–e241. 51 indexed citations

Ellinghaus, Peter, Elisabeth Perzborn, Christoph Gerdes, et al.. (2016). Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran. Thrombosis Research. 142. 44–51. 60 indexed citations

Chang, Edwin, Hongguang Liu, Kerstin Unterschemmann, et al.. (2014). 18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243. Clinical Cancer Research. 21(2). 335–346. 24 indexed citations

Härter, Michael, Karl‐Heinz Thierauch, Ajay Bhargava, et al.. (2013). Inhibition of Hypoxia‐Induced Gene Transcription by Substituted Pyrazolyl Oxadiazoles: Initial Lead Generation and Structure–Activity Relationships. ChemMedChem. 9(1). 61–66. 5 indexed citations

Paulus, Patrick, Sabine Tacke, Peter Ellinghaus, et al.. (2012). Deguelin Attenuates Reperfusion Injury and Improves Outcome after Orthotopic Lung Transplantation in the Rat. PLoS ONE. 7(6). e39265–e39265. 17 indexed citations

10.

Lenhard, Diana C., Hubertus Pietsch, Martin A. Sieber, et al.. (2012). The Osmolality of Nonionic, Iodinated Contrast Agents as an Important Factor for Renal Safety. Investigative Radiology. 47(9). 503–510. 33 indexed citations

11.

Gashaw, Isabella, Peter Ellinghaus, Anette Sommer, & Khusru Asadullah. (2011). What makes a good drug target?. Drug Discovery Today. 17. S24–S30. 65 indexed citations

12.

Jennewein, Carla, Nguyen Tran, Patrick Paulus, et al.. (2011). Novel Aspects of Fibrin(ogen) Fragments during Inflammation. Molecular Medicine. 17(5-6). 568–573. 188 indexed citations

13.

Dinh, Wilfried, Reiner Füth, Werner Nickl, et al.. (2009). Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovascular Diabetology. 8(1). 58–58. 121 indexed citations

14.

Milting, Hendrik, Peter Ellinghaus, Michael J. Seewald, et al.. (2008). Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices. The Journal of Heart and Lung Transplantation. 27(6). 589–596. 125 indexed citations

15.

Oelke, Matthias, Petter Hedlund, Knut Albrecht, et al.. (2006). Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: Immunohistochemical and molecular biology study. Urology. 67(5). 1111–1116. 30 indexed citations

16.

Ellinghaus, Peter, Robert Scheubel, Dobromir Dobrev, et al.. (2005). Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. Journal of Thoracic and Cardiovascular Surgery. 129(6). 1383–1390. 92 indexed citations

17.

Seedorf, Udo, et al.. (2000). Sterol carrier protein-2. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1486(1). 45–54. 119 indexed citations

18.

Kannenberg, Frank, Peter Ellinghaus, Gerd Assmann, & Udo Seedorf. (1999). Aberrant Oxidation of the Cholesterol Side Chain in Bile Acid Synthesis of Sterol Carrier Protein-2/Sterol Carrier Protein-x Knockout Mice. Journal of Biological Chemistry. 274(50). 35455–35460. 67 indexed citations

19.

Ellinghaus, Peter, Frank Kannenberg, Manfred Fobker, et al.. (1998). Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes & Development. 12(8). 1189–1201. 228 indexed citations

20.

Seedorf, Udo, et al.. (1996). Structure and chromosomal assignment of the murine sterol carrier protein 2 gene (<i>Scp2</i>) and two related pseudogenes by in situ hybridization. Cytogenetic and Genome Research. 73(4). 279–281. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact